Presumed Democrat presidential nominee Joe Biden this week indicated that U.S. President Donald Trump’s rush to develop a coronavirus vaccine in record time may not yield a safe and effective product that the public can trust.
“People don’t believe that he is telling the truth [about the safety of the vaccine candidates],†Biden asserted. “Therefore, they’re not at all certain they’re going to take the vaccine.â€
“It’s not likely to go through all the tests and the trials that are needed to be done,†he added, referring to the potential vaccine.
Outside of
Biden's Basement-World:
January 22, 2020 - Pharmaceuticals company Moderna working with US government to develop vaccine;
https://www.cnbc.com/2020/01/22/moderna-is-working-on-a-vaccine-for-chinas-deadly-coronavirus.html ,
https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-funding-award-cepi-accelerate-developmentFebruary 11, 2020 - HHS expands partnership with Janssen Research & Development for vaccine development;
https://www.hhs.gov/about/news/2020/02/11/hhs-janssen-join-forces-on-coronavirus-vaccine.htmlFebruary 18, 2020 - HHS to work with Sanofi Pasteur to develop coronavirus vaccine and treatment;
https://www.statnews.com/2020/02/18/sanofi-announces-it-will-work-with-hhs-to-develop-coronavirus-vaccine/February 26, 2020 - Experimental vaccine submitted for testing; Moderna,
https://www.cnn.com/2020/02/25/business/moderna-coronavirus-vaccine/index.htmlMarch 16, 2020 - Pfizer announced partnership to develop BioNTech’s mRNA-based COVID-19 vaccines;
https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_biontech_to_co_develop_potential_covid_19_vaccineMarch 16, 2020 - Testing begins of Moderna's experimental coronavirus vaccine; at Kaiser Permanente Washington Health Research Institute,
https://www.kpwashingtonresearch.org/news-and-events/recent-news/news-2020/kaiser-permanente-launches-coronavirus-vaccine-study-seattleMarch 24, 2020 - Ology Bioservices, Inovio Partner To Manufacture COVID-19 Vaccine With $11.9M DOD Grant;
http://ir.inovio.com/news-releases/news-releases-details/2020/Ology-Bioservices-Inovio-Partner-To-Manufacture-COVID-19-DNA-Vaccine-With-119-Million-Department-of-Defense-Grant/default.aspxMarch 27, 2020 - Sanofi and Translate Bio collaborate to develop COVID-19 vaccine;
https://www.sanofi.com/en/media-room/press-releases/2020/2020-03-27-07-00-00 https://investors.translate.bio/news-releases/news-release-details/sanofi-pasteur-and-translate-bio-collaborate-develop-novel-mrnaMarch 27, 2020 - Emory University began enrolling participants for a phase one clinical trial of Moderna's potential coronavirus vaccine;
https://news.emory.edu/stories/2020/03/coronavirus_vteu_modernastart/index.htmlMarch 30, 2020 - Johnson & Johnson announced selection of a lead COVID-19 vaccine candidate and an expansion of the partnership between the Janssen Pharmaceutical and BARDA;
https://www.jnj.com/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19-landmark-new-partnership-with-u-s-department-of-health-human-services-and-commitment-to-supply-one-billion-vaccines-worldwide-for-emergency-pandemic-useApril 6, 2020 - INOVIO Started Phase 1 Clinical Trial Of Its COVID-19 Vaccine;
http://ir.inovio.com/news-and-media/news/press-release-details/2020/INOVIO-Initiates-Phase-1-Clinical-Trial-Of-Its-COVID-19-Vaccine-and-Plans-First-Dose-Today/default.aspxApril 14, 2020 - Sanofi and GSK to develop a COVID-19 vaccine;
https://www.sanofi.com/en/media-room/press-releases/2020/2020-04-14-13-00-00April 16, 2020 - Moderna awarded up to $483M by BARDA to accelerate development of mRNA coronavirus vaccine;
https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-award-us-government-agency-barda-483-millionApril 22, 2020 - Pfizer and BioNTech announced approval to begin Phase 1/2 trial of BioNTech’s COVID-19 vaccines in Germany;
https://www.pfizer.com/news/press-release/press-release-detail/biontech_and_pfizer_announce_regulatory_approval_from_german_authority_paul_ehrlich_institut_to_commence_first_clinical_trial_of_covid_19_vaccine_candidatesApril 22, 2020 - Valneva and Dynavax announced collaboration to advance COVID-19 vaccine development using Dynavax's adjuvant;
https://investors.dynavax.com/news-releases/news-release-details/valneva-and-dynavax-announce-collaboration-advance-vaccineApril 23, 2020 - University of Oxford researchers began Phase I trial of a COVID-19 vaccine;
https://www.ox.ac.uk/news/2020-04-23-oxford-covid-19-vaccine-begins-human-trial-stage ,
https://www.bbc.com/news/health-52394485April 23, 2020 - Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical and Emergent BioSolutions, Inc. to support the manufacturing of its COVID-19 vaccine;
https://www.jnj.com/johnson-johnson-announces-collaboration-to-expand-manufacturing-capabilities-for-its-covid-19-vaccine-candidate-in-support-of-the-companys-goal-to-supply-more-than-one-billion-vaccine-doses-globallyApril 23, 2020 - Inovio vaccine began human trials;
https://news.yahoo.com/coronavirus-vaccine-trial-participant-signed-225702313.htmlApril 29, 2020 - Pfizer and BioNTech announced that the first cohort of BioNTech’s Phase 1/2 clinical trial has been dosed;
https://www.pfizer.com/news/press-release/press-release-detail/biontech-and-pfizer-announce-completion-dosing-first-cohortApril 30, 2020 - AstraZeneca and Oxford University announce agreement for COVID-19 vaccine;
https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/astrazeneca-and-oxford-university-announce-landmark-agreement-for-covid-19-vaccine.htmlMay 5, 2020 - Pfizer and BioNTech announced that the first participants have been dosed in the US in the Phase 1/2 clinical trial;
https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_biontech_dose_first_participants_in_the_u_s_as_part_of_global_covid_19_mrna_vaccine_development_programMay 12, 2020 - Moderna receives FDA Fast Track designation for coronavirus vaccine;
https://investors.modernatx.com/news-releases/news-release-details/moderna-receives-fda-fast-track-designation-mrna-vaccine-mrnaMay 12, 2020 - ApiJect Systems awarded $138M for pre-filled COVID-19 vaccine syringes;
https://www.upi.com/Defense-News/2020/05/12/ApiJect-Systems-awarded-138M-for-syringes-for-COVID-19-vaccine/5001589324444/May 21, 2020 - Trump Administration’s Operation Warp Speed accelerates AstraZeneca COVID-19 vaccine to be available beginning in October;
https://www.hhs.gov/about/news/2020/05/21/trump-administration-accelerates-astrazeneca-covid-19-vaccine-to-be-available-beginning-in-october.htmlMay 21, 2020 - Under Operation Warp Speed, US secures 300 million doses, almost a third, of potential AstraZeneca COVID-19 vaccine;
https://business.financialpost.com/technology/u-s-secures-300-million-doses-of-potential-astrazeneca-covid-19-vaccine-3May 21, 2020 - Under Operation Warp Speed, AstraZeneca received support of more than $1B from the US Biomedical Advanced Research and Development Authority for development, production, and delivery of the vaccine, starting in the fall; development Phase III clinical trial with 30,000 participants and a paediatric trial;
https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/astrazeneca-advances-response-to-global-covid-19-challenge-as-it-receives-first-commitments-for-oxfords-potential-new-vaccine.htmlMay 22, 2020 - University of Oxford researchers began Phase II/III trial of a COVID-19 vaccine;
https://www.ox.ac.uk/news/2020-05-22-oxford-covid-19-vaccine-begin-phase-iiiii-human-trialsMay 25, 2020 - Novavax Began Phase 1/2 Clinical Trial of COVID-19 Vaccine;
https://ir.novavax.com/news-releases/news-release-details/novavax-initiates-phase-12-clinical-trial-covid-19-vaccineMay 27, 2020 - Novavax acquired Praha Vaccines with an annual production capacity of over 1 billion doses;
https://ir.novavax.com/news-releases/news-release-details/novavax-expands-large-scale-global-manufacturing-capacityMay 29, 2020 - Moderna announces first participants dosed in Phase 2 study of coronavirus vaccine;
https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-first-participants-each-age-cohort-dosed-phaseJune 4, 2020 - Novavax announced an up to $60M contract with the US DOD for Novavax’ COVID-19 vaccine;
https://ir.novavax.com/news-releases/news-release-details/novavax-awarded-department-defense-contract-covid-19-vaccineJune 10, 2020 - Operation Warp Speed ramps up U.S.-based manufacturing capacity for vials for COVID-19 vaccines and treatments and for future needs;
https://www.hhs.gov/about/news/2020/06/11/operation-warp-speed-ramps-up-us-based-manufacturing-capacity-for-vials-for-covid-19-vaccines-and-treatments.htmlJune 10, 2020 - Janssen Pharmaceutical accelerating its Phase 1/2a trial of its COVID-19 vaccine to the second half of July;
https://www.jnj.com/johnson-johnson-announces-acceleration-of-its-covid-19-vaccine-candidate-phase-1-2a-clinical-trial-to-begin-in-second-half-of-julyJune 23, 2020 - INOVIO announced it has received $71 million funding from the DOD for large-scale manufacture of the company's devices that deliver vaccine directly into the skin;
http://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-Receives-71-Million-Contract-From-US-Department-of-Defense-To-Scale-Up-Manufacture-of-CELLECTRA-3PSP-Smart-Device-and-Procurement-of-CELLECTRA-2000-for-COVID-19-DNA-Vaccine/default.aspxJune 24, 2020 - AstraZeneca began a vaccine trial in South Africa;
https://thehill.com/policy/international/504328-large-scale-coronavirus-vaccine-trial-begins-in-south-africaJune 26, 2020 - Vaxart’s COVID-19 Vaccine Selected for the U.S. Government’s Operation Warp Speed;
https://investors.vaxart.com/news-releases/news-release-details/vaxarts-covid-19-vaccine-selected-us-governments-operation-warpJuly 8, 2020 - Moderna completed enrollment for its Phase 2 study of its vaccine;
https://investors.modernatx.com/news-releases/news-release-details/moderna-completes-enrollment-phase-2-study-its-mrna-vaccineJuly 13, 2020 - Pfizer Inc. and BioNTech announced that two of the companies’ COVID-19 vaccine candidates received Fast Track designation from the US FDA; both are currently undergoing Phase 1/2 clinical studies;
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-granted-fda-fast-track-designation-twoJuly 20, 2020 - BioNTech and Pfizer announced initial data from their Phase 1/2 trial showed the COVID-19 vaccine produced both antibodies and T-cells in patients;
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-early-positive-update-germanJuly 20, 2020 - Oxford University COVID-19 vaccine produced both antibodies and T-cells in patients;
https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2020/covid-19-vaccine-azd1222-showed-robust-immune-responses-in-all-participants-in-phase-i-ii-trial.htmlJuly 22, 2020 - Pfizer and BioNTech announced an agreement with the US HHS Department and the DoD under Operation Warp Speed to begin delivering 300 million doses of COVID-19 vaccine in 2021, with the US government receiving 100 million doses of the vaccine;
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-agreement-us-government-600 ,
https://www.bloomberg.com/news/articles/2020-07-22/pfizer-biontech-receive-u-s-order-for-covid-vaccineJuly 23, 2020 - Novavax and FUJIFILM Diosynth Biotechnologies announced today an agreement to manufacture COVID-19 vaccine, with the first batch already started at FUJIFILM's facility in North Carolina;
https://ir.novavax.com/news-releases/news-release-details/novavax-and-fujifilm-diosynth-biotechnologies-initiate-largeJuly 26, 2020 - Moderna announced a modification to its contract with BARDA for additional funding to support late development, including the expanded Phase 3 study of its COVID-19 vaccine;
https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-expansion-barda-agreement-support-larger-phaseJuly 27, 2020 - Moderna announced announced that the Phase 3 study of its COVID-19 vaccine has begun dosing participants; the randomized, placebo-controlled trial will include some 30,000 US participants;
https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-phase-3-cove-study-mrna-vaccine-against-covidJuly 27, 2020 - Pfizer and BioNTech announced the start of a global Phase 2/3 clinical study of its COVID-19 vaccine, which will include up to 30,000 participants;
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-choose-lead-mrna-vaccine-candidate-0July 27, 2020 - As part of the agreement between Novavax and FUJIFILM and of Operation Warp Speed, mass production of the Novavax COVID-19 vaccine will be done at FUJIFILM's Texas A & M University facility;
https://www.kxxv.com/brazos/u-s-chooses-texas-a-m-bio-manufacturing-center-for-production-of-covid-19-vaccine-candidatesJuly 30, 2020 - Janssen Research (Johnson & Johnson) COVID-19 vaccine began Phase I/IIa clinical trial in the US and Belgium;
https://www.jnj.com/single-dose-of-johnson-johnson-covid-19-vaccine-candidate-demonstrates-robust-protection-in-pre-clinical-studiesAugust 5, 2020 - Johnson & Johnson announced an agreement between its Janssen Pharmaceutical Companies and the US government for large scale domestic manufacturing and delivery of 100 million doses of Janssen's Covid-19 vaccine, subject to successful testing and with an option to purchase an additional 200 million doses;
https://www.janssen.com/johnson-johnson-announces-agreement-us-government-100-million-doses-investigational-covid-19-vaccineIf Biden tries the
Untested Trump Vaccine lie-narrative he'll get buried with facts. In the real world the several leading vaccine companies have been working with the Trump Administration to coordinate development, testing, and production capacity. The process has been accelerated, but testing has not been skipped.
The "Trump did nothing for two months" narrative was stupidly false, and with up to three vaccines probably being approved by the end of 2020, the Dems have the choice of having to admit (when questioned) that their narrative was false, or to attack the vaccines the way they did with HCQ. Attacking is the stupider response, and it looks like that is the Dems' choice.
